Lumida
/SNWV
⌘K
SANUWAVE Health Inc

SANUWAVE Health Inc

SNWV
$6.39USD-3.91%-0.26 today

MARKET CAP

54.9M

P/E (TTM)

6.7x

FWD P/E

4.6x

DAY RANGE

$6 – $7

52W RANGE

$6
$47

AI Summary

Stalk
TrimMedium

In a Stage 4 decline, both medium- and long-term biases remain bearish. Despite an extreme oversold bounce, price is still below the downward-sloping 9/21 EMAs without any clear rejection at resistance levels. With no definitive short-side trigger, execution should be deferred, awaiting a pullback into the EMA zone for a structurally sound short entry.

  • Q1 2026 revenue rose to $9.6 M (+3% YoY), the highest Q1 in company history.
  • Management forecasts Q2 sales of $11.1–11.6 M, implying 10–15% YoY growth.
  • Q1 operating loss of $1.1 M contrasts with prior $0.6 M profit.
Full analysis →
Insider Trades2 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 5, 2025SellSNWVPeter StegagnoChief Operating Officer3,724$22.42$54.9M-86.28%+4.57%$83.5K+0.00%Trim
May 15, 2025SellSNWVIulian CioantaChief Sci. and Tech. Officer7,278$23.65$54.9M-86.28%+4.57%$172.1K+0.00%Trim